Cardiorenal Syndrome

Renal capacity, as reflected by serum creatinine, or all the more unequivocally by assessed glomerular filtration rate (eGFR), is relentlessly the best indicator of cardiovascular results in an expansive range of populaces. This incorporates higher hazard patients, for example, those postmyocardial localized necrosis, and those with diabetes or congestive cardiovascular breakdown. The new center ought to be to perceive the cardiorenal disorder, and treat the entire patient, and treat for long haul.

    Related Conference of Cardiorenal Syndrome

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    September 22-23, 2025

    7th International Conference on Clinical Immunology, Neuropharmacology and Drug Development

    Amsterdam, Netherlands
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    November 19-20, 2025

    14th International Conference on Nephrology & Therapeutics

    Paris, France
    November 21-22, 2025

    23rd International Conference on Nephrology, Urology and Therapeutics

    Dubai, UAE
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    6th International Conference on Kidney Failure & Renal Care

    London, UK
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    April 23-24, 2026

    14th European Congress on Nephrology, Internal Medicine and Kidney Diseases

    Paris, France
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Cardiorenal Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in